2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
- C. Yancy, M. Jessup, B. Wilkoff
- MedicineCirculation
- 2013
WRITING COMMITTEE MEMBERS* Clyde W. Yancy, MD, MSc, FACC, FAHA, Chairyz; Mariell Jessup,MD, F ACC,FAHA, Vice Chair*y; Biykem Bozkurt, MD; Javed Butler, MBBS, MSPH, Facc, FAhay; Japed Butler,MBBS, FAcc, FA HAy; Donald E.
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
- C. Yancy, M. Jessup, B. Wilkoff
- MedicineJournal of the American College of Cardiology
- 15 October 2013
Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association
- P. Heidenreich, J. Trogdon, Y. Woo
- MedicineCirculation
- 1 March 2011
Findings indicate CVD prevalence and costs are projected to increase substantially and effective prevention strategies are needed if the authors are to limit the growing burden of CVD.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or absence of diabetes.
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
- C. Yancy, M. Jessup, B. Wilkoff
- MedicineCirculation
- 15 October 2013
The medical profession should play a central role in evaluating the evidence related to drugs, according to a report by the World Health Organization and the European Medicines Agency.
Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association
- P. Heidenreich, N. Albert, J. Trogdon
- Medicine, Political ScienceCirculation: Heart Failure
- 1 May 2013
The estimated prevalence and cost of care for HF will increase markedly because of aging of the population and strategies to prevent HF and improve the efficiency of care are needed.
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical…
- C. Yancy, M. Jessup, C. Westlake
- MedicineJournal of the American College of Cardiology
- 8 August 2017
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.
- A. Ambrosy, G. Fonarow, M. Gheorghiade
- Medicine, Political ScienceJournal of the American College of Cardiology
- 1 April 2014
The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
- F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, J. Butler
- Biology, MedicineJournal of the American College of Cardiology
- 3 November 2009
...
...